Cargando…

Cost-effectiveness and long-term outcomes of liver transplantation using hepatitis B core antibody-positive grafts with hepatitis B immunoglobulin prophylaxis in Korea

BACKGROUND/AIMS: Hepatitis B core antibody (anti-HBc)-positive donors are used as an extended donor pool, and current guidelines recommend the usage of nucleos(t)ide analogues (NAs) as prophylaxis for preventing de novo hepatitis B virus infection (DNH). We analyzed the long-term outcomes of a large...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Kyeong Deok, Lee, Ji Eun, Kim, Jong Man, Lee, Okjoo, Hwang, Na Young, Rhu, Jinsoo, Choi, Gyu-Seong, Kim, Kyunga, Joh, Jae-Won
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Association for the Study of the Liver 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8524070/ https://www.ncbi.nlm.nih.gov/pubmed/34492755 http://dx.doi.org/10.3350/cmh.2021.0137

Ejemplares similares

Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver Transplantation
por: Lee, Okjoo, et al.
Publicado: (2022)

Tenofovir does not induce renal dysfunction compared to entecavir in post-liver-transplant hepatitis B virus patients
por: Kim, Sang Jin, et al.
Publicado: (2020)

Prediction model for early graft failure after liver transplantation using aspartate aminotransferase, total bilirubin and coagulation factor
por: Rhu, Jinsoo, et al.
Publicado: (2021)

Fibrosis-4 index, a predictor for prognosis of hepatocellular carcinoma patients after curative hepatectomy even in hepatitis B virus dominant populations
por: Yun, Sang Oh, et al.
Publicado: (2023)

Surgical treatment outcomes of primary hepatic sarcomas: A single-center experience
por: Kim, Sang Jin, et al.
Publicado: (2021)

Hepatic venous territory mapping in living donor liver transplantation using right liver graft: an objective parameter for venous reconstruction
por: Yang, Jaehun, et al.
Publicado: (2023)

Hepatocellular Carcinoma Arising from Hepatocellular Adenoma in an Elderly Male Patient
por: Lim, Manuel, et al.
Publicado: (2021)

Determination of Hepatitis B Immunoglobulin Infusion Interval Using Pharmacokinetic Half-life Simulation for Posttransplant Hepatitis B Prophylaxis
por: Hwang, Shin, et al.
Publicado: (2019)

Hepatitis B Prophylaxis after Liver Transplantation in Korea: Analysis of the KOTRY Database
por: Park, Gil-Chun, et al.
Publicado: (2020)

Hepatectomy outcomes in patients with hepatitis C virus-related hepatocellular carcinoma with or without cirrhosis
por: Kim, Jong Man, et al.
Publicado: (2022)

Adjuvant therapy using ex vivo-expanded allogenic natural killer cells in hepatectomy patients with hepatitis B virus related solitary hepatocellular carcinoma: MG4101 study
por: Kim, Jong Man, et al.
Publicado: (2021)

Impact of Graft Weight Change During Perfusion on Hepatocellular Carcinoma Recurrence After Living Donor Liver Transplantation
por: Kim, Jong Man, et al.
Publicado: (2021)

The clinical impact of donor against recipient HLA one way mismatch on the occurrence of graft versus host disease in liver transplantation
por: Kim, Sang Jin, et al.
Publicado: (2022)

Adult Living Donor Liver Transplantation Using Hepatitis B Core Antibody-Positive Grafts in Korea, a Hepatitis B-endemic Region
por: Kim, Hee Yeon, et al.
Publicado: (2011)

Author Correction: The clinical impact of donor against recipient HLA one way mismatch on the occurrence of graft versus host disease in liver transplantation
por: Kim, Sang Jin, et al.
Publicado: (2022)

Recurrence of Hepatitis B Infection in Liver Transplant Patients Receiving Long-Term Hepatitis B Immunoglobulin Prophylaxis
por: Beckebaum, Susanne, et al.
Publicado: (2018)

Hepatitis B immunoglobulin prophylaxis for de novo hepatitis B infection in liver transplantation: a 30-year experience
por: Jung, Hye-Sol, et al.
Publicado: (2022)

Antibodies against Hepatitis A and Hepatitis B Virus in Intravenous Immunoglobulin Products
por: Lee, Soyoung, et al.
Publicado: (2016)

Is Hepatitis B Immunoglobulin Necessary in Prophylaxis of Hepatitis B Recurrence after Liver Transplantation? A Meta-Analysis
por: Wang, Peijie, et al.
Publicado: (2014)

Early use of everolimus improved renal function after adult deceased donor liver transplantation
por: Lee, Seohee, et al.
Publicado: (2021)

Upper thigh skeletal muscle index predicts outcomes in liver transplant recipients
por: Lim, Manuel, et al.
Publicado: (2023)

Hepatitis B Core Antigen Expression in Hepatocytes Reflects Viral Response to Entecavir in Chronic Hepatitis B Patients
por: Lee, Jeong Guil, et al.
Publicado: (2013)

Risk factors for poor survival after recurrence of hepatocellular carcinoma after liver transplantation
por: Kim, Minjeong, et al.
Publicado: (2021)

A Multicenter Phase III Study to Evaluate the Efficacy and Safety of Hepabulin, a New Hepatitis B Immunoglobulin, in Liver Transplantation Recipients with Hepatitis B
por: Choi, Ho Joong, et al.
Publicado: (2017)

Tablet or capsule form of generic mycophenolate mofetil (My-Rept(®)) after liver transplantation: a prospective randomized trial
por: Kim, Jong Man, et al.
Publicado: (2019)

3D Printing Model of Abdominal Cavity of Liver Transplantation Recipient to Prevent Large-for-Size Syndrome
por: Park, Sunghae, et al.
Publicado: (2022)

De novo hepatitis B virus infection developing after liver transplantation using a graft positive for hepatitis B core antibody
por: Han, Jae Hyun, et al.
Publicado: (2015)

Comparison of liver regeneration in laparoscopic versus open right hemihepatectomy for adult living donor liver transplantation
por: Yang, Jaehun, et al.
Publicado: (2020)

Early reoperation after adult living-donor liver transplantation is associated with poor survival
por: Lim, Manuel, et al.
Publicado: (2019)

Ventilator support in the pretransplant period predisposes early graft failure after deceased donor liver transplantation
por: Lee, Nuri, et al.
Publicado: (2023)

Long-Term Outcomes of Liver Transplantation in Hepatocellular Carcinoma with Bile Duct Tumor Thrombus: A Comparison with Portal Vein Tumor Thrombus
por: Lee, Ji Soo, et al.
Publicado: (2023)

Application of three-dimensional printing for intraoperative guidance during liver resection of a hepatocellular carcinoma with sophisticated location
por: Rhu, Jinsoo, et al.
Publicado: (2021)

Indications for open hepatectomy in the era of laparoscopic liver resection: a high volume single institutional study
por: Jo, Sung Jun, et al.
Publicado: (2022)

Expression of Hepatocyte Hepatitis B Core Antigen and Hepatitis B Surface Antigen as a Marker in the Management of Chronic Hepatitis B Patients
por: Yim, Sun Young, et al.
Publicado: (2017)

Reusing hepatic grafts in Korea: a case report
por: Kim, Hye Young, et al.
Publicado: (2021)

A 6-month mixed-effect pharmacokinetic model for post-transplant intravenous anti-hepatitis B immunoglobulin prophylaxis
por: Han, Seunghoon, et al.
Publicado: (2017)

Recipient efficacy and safety of kidney transplantation from older living donor: consideration for using older kidney as a solution to the shortage of organs
por: Song, Ji Yeon, et al.
Publicado: (2021)

Continuing five or more locoregional therapies before living donor salvage liver transplantation for hepatocellular carcinoma is related to poor recurrence-free survival
por: Rhu, Jinsoo, et al.
Publicado: (2018)

Intraoperative Ultrasonography as a Guidance for Dividing Bile Duct During Laparoscopic Living Donor Hepatectomy
por: Rhu, Jinsoo, et al.
Publicado: (2019)

Core indicators related to the elimination of hepatitis B and C virus infection in South Korea: A nationwide study
por: Lee, Chang Hun, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6sfo5onjpq7orn300kkr9gos52